🟢 Connect Biopharma is trading 6.69% up today in pre-market with no verified company-specific catalyst identified

Connect Biopharma is trading 6.69% up at $2.66 after no verified company-specific catalyst was identified for August 18, 2026.

• The latest material announcement was the August 12 second-quarter update, which reported completed enrollment in Phase 2 Seabreeze STAT asthma and COPD studies and anticipated September topline results.
• Broader markets are weaker, so the pre-market gain appears unsupported by current market direction; confidence remains low.